Provider QP48-23 Update for New to Market Medical Drugs: delandistrogene moxeparvovec and epcoritamab Read More
Provider QP49-23 Register for Webinar | Trauma-Informed Care 101 | Thursday, June 29, 5-6:30 pm Read More
Provider QP51-23 Commercial Pharmacy Benefit Exclusion for Aponvie™, Iheezo™, Omisirge®, and Qalsody™ Read More
Provider QP53-23 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective August 1, 2023 Read More
